| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Doherty David T | Chief Financial Officer | C/O SURGERY PARTNERS, INC., 340 SEVEN SPRINGS WAY, SUITE 600, BRENTWOOD | /s/ Jennifer Baldock, Attorney-in-Fact | 16 Mar 2026 | 0001908911 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SGRY | Common Stock | Sale | $110,838 | -8,867 | -3.8% | $12.50 | 221,679 | 16 Mar 2026 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Shares sold to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock on March 4, 2026. |
| F2 | The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |